Galectin Therapeutics Inc

NASDAQ:GALT   10:12:23 AM EDT
2.42
+0.06 (+2.54%)
Earnings Announcements

Galectin Therapeutics Reports Qtrly Loss Per Share $0.14

Published: 11/15/2021 14:01 GMT
Galectin Therapeutics Inc (GALT) - Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2021, and Provides Business Update.
Quarterly Loss per Share $0.14.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.